The U.S. Centers for Disease Control and Prevention is observing a lower rate of severe allergic reactions in people in the United States who have received Pfizer Inc. and BioNTech SE’s Covid-19 vaccine.

Severe allergic reactions to Moderna Inc.’s coronavirus vaccine appear to be quite rare, the U.S. Centers for Disease Control and Prevention (CDC) said, after more than 4 million people received their first dose.

Is fear a powerful marketing tool for pharmaceutical companies? The answer is yes, according to an Advertising Age report.

Adamis Pharmaceuticals Corp said the U.S. Food and Drug Administration rejected its emergency treatment for acute anaphylaxis, a severe allergic reaction, for the second time.

French drugmaker Sanofi SA said it was voluntarily recalling all its Auvi-Q injections in the United States to treat patients with severe allergic reactions. The company said on Wednesday its U.S. unit was recalling the injections as they could potentially deliver an inaccurate dose. Auvi-Q is designed to treat anaphylaxis, a potentially fatal allergic reaction, […]